Stay updated on ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial

Sign up to get notified when there's something new on the ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The NIH announcement about terminology changes during an agency transition was removed from the page banner. The study record area continues to show a 403 Forbidden error.
    Difference
    1%
    Check dated 2026-11-08T05:48:45.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.2 to v3.8.0 while the page remained a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T03:56:11.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A banner announces changes to NIH websites and says the term “Super Intelligence” is being used in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T04:48:42.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T04:00:36.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T08:17:52.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the expected study record content with a generic error page. Access to the study details is blocked, though the site chrome (header/footer) remains visible.
    Difference
    21%
    Check dated 2026-09-20T03:06:37.000Z thumbnail image

Stay in the know with updates to ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial page.